Results 101 to 110 of about 2,929 (132)

GMP Manufacturing and Characterization of the HIV Booster Immunogen HxB2.WT.Core-C4b for Germline Targeting Vaccine Strategies. [PDF]

Vaccines (Basel)
Pallerla S, Kallur Siddaramaiah L, Mundsperger P, Katinger D, Fauland K, Kreismayr G, Weik R, Arslan O, Shen M, Ozorowski G, Lee WH, Ward AB, Baboo S, Diedrich JK, Yates JR, Paulson JC, Blumen T, Craig D, Swoyer R, Yuan M, Stamatatos L.   +20 more
europepmc   +1 more source

Lab-scale production of postbiotic proteins from <i>Bifidobacterium adolescentis</i> with antiviral and epithelial-protective properties. [PDF]

Front Microbiol
Hernández M, Quevedo B, Cabrera M, Ulloa J.   +3 more
europepmc   +1 more source

Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe disease. [PDF]

Front Immunol
Parsons E, Lu Z, Richard SA, Zelkoski A, Le J, Palanikumar N, Nguyen P, Alba C, Sukumar G, Rosenberger J, Zhang X, Burgess TH, Colombo R, Mende K, Berjohn C, Epsi N, Agan BK, Tribble D, Lindholm DA, Dalgard CL, Pollett SD, Malloy AMW, EPICC COVID-19 Cohort Study Group.   +22 more
europepmc   +1 more source

Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. [PDF]

Vaccines (Basel)
Göbel S, Kazemi O, Ma J, Jordan I, Sandig V, Paulissen J, Kerstens W, Thibaut HJ, Reichl U, Dallmeier K, Genzel Y.   +10 more
europepmc   +1 more source

Somatic Embryogenesis: A Biotechnological Route in the Production of Recombinant Proteins. [PDF]

BioTech (Basel)
Ramírez-Mosqueda MA, Cadena-Zamudio JD, Cruz-Cruz CA, Aguirre-Noyola JL, Barbón R, Gómez-Kosky R, Angulo C.   +6 more
europepmc   +1 more source

Virus-like particle vaccine with authentic quaternary epitopes protects against Zika virus-induced viremia and testicular damage. [PDF]

J Virol
Abbo SR, Yan K, Geertsema C, Hick TAH, Altenburg JJ, Nowee G, van Toor C, van Lent JW, Nakayama E, Tang B, Metz SW, Bhowmik R, de Silva AM, Prow NA, Correia R, Alves PM, Roldão A, Martens DE, van Oers MM, Suhrbier A, Pijlman GP.   +20 more
europepmc   +1 more source

Process Intensification for Recombinant Marburg Virus Glycoprotein Production Using <i>Drosophila</i> S2 Cells. [PDF]

Eng Life Sci
Göbel S, Mayerlen L, Eiser IY, Fichtmueller L, Clements D, Reichl U, Genzel Y, Lehrer A.   +7 more
europepmc   +1 more source

Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO Cells. [PDF]

Biotechnol J
Wu MYM, Rocamora F, Robinson CM, Shin S, Maurya S, Toth EA, Fuerst TR, Lewis NE.   +7 more
europepmc   +1 more source

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. [PDF]

NPJ Vaccines
Modjarrad K, Che Y, Chen W, Wu H, Cadima CI, Muik A, Maddur MS, Tompkins KR, Martinez LT, Cai H, Ramos M, Mensah S, Cumbia B, Falcao L, McKeen AP, Chang JS, Fennell KF, Huynh KW, McLellan TJ, Sahasrabudhe PV, Chen W, Cerswell M, Garcia MA, Li S, Sharma R, Li W, Dizon KP, Duarte S, Gillett F, Smith R, Illenberger DM, Efferen KS, Vogel AB, Anderson AS, Şahin U, Swanson KA.   +35 more
europepmc   +1 more source

Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions¹. [PDF]

Emerg Infect Dis
Bus-Jacobs L, Lau R, Soethoudt M, Gebbia L, Janssens E, Hermans T.   +5 more
europepmc   +1 more source